HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis

HJ11 is a novel traditional Chinese medicine developed from the appropriate addition and reduction of Si-Miao-Yong-An decoction, which has been commonly used to treat ischemia-reperfusion (I/R) injury in the clinical setting. However, the mechanism of action of HJ11 components remains unclear. Ferro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangyuan, Li, Ziyun, Gao, Ping, Zou, Jiaxi, Cui, Yuting, Qian, Yi, Gu, Renjun, Xu, Weiming, Hu, Jingqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723372/
https://www.ncbi.nlm.nih.gov/pubmed/36483736
http://dx.doi.org/10.3389/fphar.2022.1024292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723372/
https://www.ncbi.nlm.nih.gov/pubmed/36483736
http://dx.doi.org/10.3389/fphar.2022.1024292

Ejemplares similares